ArticleThe Lancet. Oncology2017
miR-16: expanding the range of molecular targets in mesothelioma.
Dean FennellPubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleThe Lancet. Oncology2017
Dean FennellPubMed ↗Publisher ↗
No numbers read from the abstract.